These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 18537642)

  • 21. Kainate and AMPA receptors in epilepsy: Cell biology, signalling pathways and possible crosstalk.
    Henley JM; Nair JD; Seager R; Yucel BP; Woodhall G; Henley BS; Talandyte K; Needs HI; Wilkinson KA
    Neuropharmacology; 2021 Sep; 195():108569. PubMed ID: 33915142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The implication of AMPA receptor in synaptic plasticity impairment and intellectual disability in fragile X syndrome.
    Cheng GR; Li XY; Xiang YD; Liu D; McClintock SM; Zeng Y
    Physiol Res; 2017 Nov; 66(5):715-727. PubMed ID: 28730825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The activation of glutamate receptors by kainic acid and domoic acid.
    Hampson DR; Manalo JL
    Nat Toxins; 1998; 6(3-4):153-8. PubMed ID: 10223631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ionotropic glutamate receptor biology: effect on synaptic connectivity and function in neurological disease.
    Barnes GN; Slevin JT
    Curr Med Chem; 2003 Oct; 10(20):2059-72. PubMed ID: 12871085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ionotropic and metabotropic kainate receptor signalling regulates Cl
    Garand D; Mahadevan V; Woodin MA
    J Physiol; 2019 Mar; 597(6):1677-1690. PubMed ID: 30570751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xenon reduces glutamate-, AMPA-, and kainate-induced membrane currents in cortical neurones.
    Dinse A; Föhr KJ; Georgieff M; Beyer C; Bulling A; Weigt HU
    Br J Anaesth; 2005 Apr; 94(4):479-85. PubMed ID: 15695547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective modulation of desensitization at AMPA versus kainate receptors by cyclothiazide and concanavalin A.
    Partin KM; Patneau DK; Winters CA; Mayer ML; Buonanno A
    Neuron; 1993 Dec; 11(6):1069-82. PubMed ID: 7506043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of desensitization at glutamate receptors in isolated crucian carp horizontal cells by concanavalin A, cyclothiazide, aniracetam and PEPA.
    Shen Y; Lu T; Yang XL
    Neuroscience; 1999 Mar; 89(3):979-90. PubMed ID: 10199629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA aptamers for AMPA receptors.
    Huang Z; Niu L
    Neuropharmacology; 2021 Nov; 199():108761. PubMed ID: 34509496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of kainic acid/AMPA and metabotropic glutamate receptors in the regulation of opioid mRNA expression and the onset of pain-related behavior following excitotoxic spinal cord injury.
    Abraham KE; McGinty JF; Brewer KL
    Neuroscience; 2001; 104(3):863-74. PubMed ID: 11440816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging structural insights into the function of ionotropic glutamate receptors.
    Karakas E; Regan MC; Furukawa H
    Trends Biochem Sci; 2015 Jun; 40(6):328-37. PubMed ID: 25941168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of risperidone on glutamate receptor subtypes in developing rat brain.
    Choi YK; Gardner MP; Tarazi FI
    Eur Neuropsychopharmacol; 2009 Feb; 19(2):77-84. PubMed ID: 18845422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term effects of olanzapine, risperidone, and quetiapine on ionotropic glutamate receptor types: implications for antipsychotic drug treatment.
    Tarazi FI; Baldessarini RJ; Kula NS; Zhang K
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1145-51. PubMed ID: 12829726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in excitatory and inhibitory receptor expression and network activity during induction and establishment of epilepsy in the rat Reduced Intensity Status Epilepticus (RISE) model.
    Needs HI; Henley BS; Cavallo D; Gurung S; Modebadze T; Woodhall G; Henley JM
    Neuropharmacology; 2019 Nov; 158():107728. PubMed ID: 31356824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy.
    Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G
    Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Stimulant amino acids, glutamate receptors and pathology of the central nervous system].
    Raevskiĭ KS
    Patol Fiziol Eksp Ter; 1990; (1):3-9. PubMed ID: 1972271
    [No Abstract]   [Full Text] [Related]  

  • 37. Kainate Receptors Play a Role in Modulating Synaptic Transmission in the Olfactory Bulb.
    Blakemore LJ; Corthell JT; Trombley PQ
    Neuroscience; 2018 Nov; 391():25-49. PubMed ID: 30213766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GABA and glutamate receptors as therapeutic targets in neurodegenerative disorders.
    Krogsgaard-Larsen P
    Pharmacol Toxicol; 1992 Feb; 70(2):95-104. PubMed ID: 1354863
    [No Abstract]   [Full Text] [Related]  

  • 39. Metazoan evolution and diversity of glutamate receptors and their auxiliary subunits.
    Ramos-Vicente D; Grant SG; Bayés À
    Neuropharmacology; 2021 Sep; 195():108640. PubMed ID: 34116111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute effects of ethanol on glutamate receptors.
    Möykkynen T; Korpi ER
    Basic Clin Pharmacol Toxicol; 2012 Jul; 111(1):4-13. PubMed ID: 22429661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.